chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This 61 year old retired patient, reported receipt of influenza vaccine in 1976 "that had the wrong strength". He remembers about 20 minutes after the vaccination he complained of nausea, vomiting and had a fever that resulted in a three day hospital admission. He denied any muscle weakness, tingling, loss of sensation or paralysis. He advised he was there for a modified 3 week Basic Training Course in November 1976 when he received the influenza vaccination. He stated he has been unable to obtain or locate these 1976 records or records for a 1985 Influenza vaccination that also resulted in 3-4 days of headaches, nausea, vomiting, runny nose and congestion. He remembers being told never to get the influenza vaccine. He did receive other vaccinations during his career and lifetime without difficulty, including 4 other influenza vaccinations (per medical records). He denied any egg, food, chemical or latex allergies. He does have seasonal allergies. A review of archived medical records showed scattered records from 1969 to 1995. However there were no records for the 1976 or 1985 events. His records document handwritten receipt of influenza TIV vaccinations in 1990, 1991, 1992, and 1994 with no adverse event. At this time, he advised he worked in immunizations and reported he was administering vaccinations; however, he does not recall receiving any influenza vaccination since 1985. His records did documents reported symptoms of nausea, vomiting, hot/cold chills, lower abdominal cramping, weakness and dizziness, headache and/or loss of appetite with diagnoses of acute gastroenteritis (AGE) and migraines on 10/19/1980, 1/4/1981, 12/19/1984, and 4/15/1986. A review of limited 1985 records listed 4 evaluation for chronic left Achilles tendonitis (onset 1983) treated with various NSAIDs (MOTRIN, INDOCIN, TOLECTIN DS and oral prednisone and IM KENALOG (to joints)). There were no exacerbations of health issues between 1990-1994 vaccinations (treated for chronic bilateral achilles tendonitis). He began documenting "severe flu symptoms in 1976" to his SF93 annual physical forms in 1995. In 2013, he reported he had not received any influenza vaccination since 1985.
6 cm diameter red area at administration site.  Warm-hot to touch.  Slightly firm to touch.  Tenderness reported.
ON 8/20/19 PATIENT MADE US AWARE THAT APPROXIMATELY 5 HOURS AFTER RECEIVING SHINGRIX INJECTION ON 8/7/19 FOR THE FIRST TIME HE DEVELOPED A GENERALIZED FLUSHING EFFECT THROUGH OUT HIS BODY THAT LASTED 3 DAYS. HE STATED HE DID NOT HAVE FEVER, BUT JUST FLUSHING.
Site: Pain at Injection Site-Severe, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.), Additional Details: suspected bursitis - pt reports injection site pain and shoulder pain post injecion. pt is having trouble lifting arm. pt has been taking motrin for pain and is going to see the orthopedic doctor to get potenital cortisone shot. it has been going on for roughly 2 weeks.
I was positive for COVID-19 on 05MAR2023, I was having a terrible cough I couldn't get rid off. A little bit of sore throat, low grade fever. At that time I had available test kit and I tested and it was positive, after I took the test I called my doctor and she had me pick up Paxlovid. I started taking it right away, I started feeling better about 3 days after. I feel a lot better now.
fever; body aches; injection site reaction; injection site itching; flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, general body pain, injection site reaction, pruritus and influenza-like symptoms. On an unknown date, the outcome of the fever, general body pain, injection site reaction, pruritus and influenza-like symptoms were unknown.   It was unknown if the reporter considered the fever, general body pain, injection site reaction, pruritus and influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The patient reported that, after vacccination with dose of Shingrix, the patient experienced fever, general body pain, injection site reaction, itching and influenza-like symptoms. The patient asked if should get 2nd dose of Shingrix.
This spontaneous report as received from a nurse refers to multiple patients of unknown age and gender. On an unknown date, the patients were vaccinated with doses of improperly stored PROQUAD subcutaneous (dose, lot number were not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
1/14/22 (5 minutes after Moderna booster shot): periods of flushness, dizziness, tingling sensations throughout body. 1/14/22-1/15/22 (night of shot and into the following days morning): body ache, restlessness, chills, headache, injection site pain- TREATMENT: Tylenol, ibuprofen, sleep. 1/15/22 (entire day after shot): body ache, headache, fatigue, injection site pain TREATMENT: Tylenol, ibuprofen, sleep. 1/16/22 (2 days after shot): slight body ache, slight fatigue, slight headache, slight injection site pain.
pt grandma went to check pt & found pt to be restless-flopping head side to side;extremities & head felt cold;grandma placed pt in bed-pt was completely still x 15min;arms were floppy;heart sound were faint;?shock-collapse or hypotonic
Dizziness flushing on L side, numbness through teeth and lips, swelling under L eye, L arm swelling, Narrative:
This is a 63-year-old male with PMH of MI - CABG quadruple bypass 2007, non-Hodgkin's lymphoma march 2021 - was treated with radiation, HTN, presents to the ED for evaluation of ear pain and headaches. Patient was seen at this facility on 01/06 22 for similar symptoms and had a CT scan of mastoids which shows maxillary sinusitis. Patient was advised to follow-up with ENT which he did in NYC. Patient was advised to follow-up with neurologist in which he has an appointment with Dr. on 01/13. Patient reports his symptoms started last week since Jan 4th with left ear pain radiated to the left jaw and headaches. Patient was seen by Dr., PMD on 01/05 and was placed on Z-Pak in which he completed. On 1/9 patient reports he started to develop blister on the left ear and noticed some lumps on the top of the left side of his head, left side of his jaw, neck and on the left side of the upper chest area. In the ED patient was medicated with 0.5 mg of hydromorphone, patient was started on acyclovir IV. Patient was also given 1 L normal saline IV fluid bolus and 1000 mg of Ofirmev. Upon arrival in the ED T-max was 100°. Vital signs stable. Patient was also tested positive for COVID-19. Pt denies any vision changes. Patient was recorded 92% on room air in the ED.
Worsening tinnitus; This is a spontaneous report from a contactable physician (patient himself). A 52-year-old male patient received bnt162b2 (Pfizer, formulation: solution of injection; Lot number: EL1284), dose 1 via an unspecified route of administration administered in left arm on 04Jan2021 06:30 AM as dose 1, single for covid-19 immunisation. Medical history included allergies for Sulfa and hypertension (htn) from an unknown date and unknown if ongoing. Concomitant medication included amlodipine; colecalciferol (VITAMIN D [COLECALCIFEROL]) and famotidine; all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported worsening tinnitus in Feb2021. Patient did not receive any treatment for the event. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
burning in arm at injection site; numbness in arm at injection site; Hard to swallow; saliva was coming out of Lips; numbness spread from shoulder to neck to back of head, around front of head down to face and to lip; A spontaneous report was received from a reporter(Health care professional) concerning 51 year old, female patient , who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced burning and numbness in arm at the site of injection, numbness spread from shoulder to neck to back of head, around front of head down to face and to lip, drooling, dysphagia.  The patient medical history was not provided. The relevant concomitant medications were also not provided.  On 31-DEC-2020, prior to the consent of the events, the patients received one dose of mRNA-1273(batch number: 026L20A) through intramuscularly in the left arm for prophylaxis of COVID-19 injection.  On 31-DEC2021, the patient experienced injection site pain, burning,  numbness in arm, shoulder, neck, back of the head, lip and face, hard to swallow and drooling. The patient had undergone CT scan of head, MRI of the brain with contrast, Chest X-ray ang EKG as well as lab work. She was referred to a neurologist and has an April appointment. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events were resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
patient had third dose. We did not know that he already completed the series, so the patient was given a third dose.
Patient states she was walking to her car when she felt her heart beating rapidly and found it hard to breath. She used her inhaler and went to the ER. Hospital given Benadryl orally.
patient came in to receive Moderna bivalent booster: booster dose to be given was 0.50 ml and the patient actually received 0.25 ml
Developed immediate pain at site of injection and a lump in area the same day.  Has had ongoing pain in that area since injection. Lump still present.  Has lost some range of motion (especially overhead extension of left arm). Continues to have pain in areas when she uses it.
Case presented to hospital with "heart attack like symptoms". Family members thought that she may be having a stroke.
Patient received Jansen and Jansen covid vaccine at 17 years old. Parents are aware and the child did not have any physical reaction to the vaccine. The mother stated she thought because the parents consented to him having it at 17 that is was ok. The pharmacist didn't catch it.
Erythema noticed by parent this AM 6/18/10. Per doctor pt to start BACTRIM 400/5 2 tsp BID x 10 days, BACTROBAN ointment to inj site QID; and maternal anxiety; pt going out of town with grandparent.
generalized fatigue evening vax given nausea on the next day w/fatigue increasing; fatigue lasted 2nd day p/vax;
Information has been received from a RN concerning a 16 year old female who was vaccinated with her first dose of GARDASIL on an unspecified date (injection). The patient developed "flu-like" symptoms and diarrhea the next day after receiving the first dose of GARDASIL. Lot # is not available. The patient sought medical attention by visiting the nurse's office. Additional information has been requested. Information has been received from a physician concerning a 16 year old female with nuts allergy who on 19-JAN-2009 at 12:30 was vaccinated with the third dose of GARDASIL (lot# 661841/0653X). On 12-JAN-2009 the patietn experienced vomiting (2 days), diarrhea, stomach pain and fever after the third dose of vaccine received. The patient experienced vomiting since 21-JAN-2009. Relevant diagnostic tests or laboratory tests included complete blood cell with differenctial/pltelet test, comprehensive metabolic panel test, urinalysis (routine), lipid panel test, urine culture (routine) and venipuncture test. Results indicated blood eosinophilic leukocyte count and absolute blood eosinophilic  leukocyte count were high (8 and 0.5x10H3/uL respectively, reference level: 0-4 and 0.0-0.4 x10K0/uL respectively). The apperance of urine was turbid abnormal. Occult blood test indicated trace abnormal. The outcome was unknown. The patient sought medical attention by visiting the nurse's office. Additional information has been requested.
ongoing symptoms of headache, muscle aches, fatigue, insomnia, elevated temperature( no fever above 99 degrees) joint aches, swollen lymph nodes, sweats, scratchy throat, red irritated eyes, bowel cramps and nausea
Felt lightheaded for a second. Told Manager I was going home, not feeling well. Started sweating on the way home. Primary Care Physician said to to to Emergency room. Got to the emergency room, blood pressure was Okay. Heart Rate was 190. Stayed over night, no diagnosis was given. Tests showed no Afib, no heart attack, no stroke. Went home next day.
Initial report received from a health care provider on 4/13/06. A patient, of unknown age and gender, had received an injection of Fluzone SV, lot number not reported and date of vaccination not reported. Per the reporter the patient had developed pancytopenia. The recovery status was not provided, and additional information was not provided. (OMIC)
Approx. 10-12 post immunization, pt. reports dizziness and nausea. She refused to lay down, remained in wheelchair. She asked for cola, it helped settle stomach. As dizziness subsided she had HA. We observed her for an additional 30 min. until dizziness gone. She still had some nausea & HA. Hx: migraines. (She often feels dizzy/nausea prior to migraines)
Fussier infant then usual, which lasted an extended period. Also, sleep disturbances. Symptoms seemed to resolve on 9/22/09 after 12 days. No treatment or significant fever.
No symptoms immediately after first shot except after 13 days later woke up with pain in arm (same arm as injection). Pain is still present after 3 days. Taking ibuprofen, ben-gay, and heating pad with essentially no effect. If I keep arm elevated the pain is slightly less. Not able to sleep due to discomfort on Day 2 and was able to sleep on Day 3 although woke up at 2am and put on ben-gay and heating pad. Constant pain limiting mobility in arm.
Had severe migraine headache starting the night of COVID-19 booster shot from Pfizer. (first vaccination was Janssen single shot) After this initial migraine, I had a migraine each time I had alcohol, even one glass of wine. This persisted for 5 weeks and then stopped.
T105.5 w/in 6hr p/vax lasting for 24hr;glazed expression;
I had fever and the place i got the shot i had redness, it didn't went away a couple of days later it was more red and it finally went away the 5th day and then on the 9th day i got the biggest redness at the same spot.
Information has been received from a healthcare worker (certified medical Assistant (C.M.A)) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 24-FEB-2015, the patient was administered with a dose of improperly stored ZOSTAVAX (lot#, expiration date and dose not provided), subcutaneously. No adverse effects were reported. This one of several reports received from the same source. Additional information has been requested.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 13-MAR-2013, the patient was vaccinated at a clinic with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 31-MAR-2013, on a few days after being vaccinated, she was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
for COVID-19 immunisation. Medical history included hypertension, bladder cancer and mitral valve prolapse, started on unknown dates. Concomitant medication included alprenolol hydrochloride (ATENENOL), atorvastatin (MANUFACTURER UNKNOWN) all taken for unknown indication, since an unspecified date. The patient was allergic to sulfanamide drugs and shrimp. Since the vaccination, the patient had not been tested for COVID-19. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. On 26Mar2021 at 01:00 the patient experienced swollen eyelid. The patient's eyelids were extremely swollen. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was reported that the patient didn't receive any treatment for the adverse event swollen eyelid. The clinical outcome of the event swollen eyelid was not recovered.   No follow-up attempts possible. No further information expected.
pt recv vax 1MAR96 & 4MAR96 pt devel a positive TB skin test p/PPD;MD reported that the pt sister also had a false positive TB skin test on 4MAR96 p/varicella vax;
This child had documented scleral icterus x 1 year with normal liver enzymes and function tests presumed Gilberts syndrome. Presented to us 8/17/2000 with worsening scleral icterus x 3.
No additional AE reported; Nurse reports products that experienced temperature excursion over the weekend were administered to a patient. Products were administered 2/13/2023.       ?    Names of vaccines involved (including lot/exp) PEDVAX HIB W015926 2/14/2025; ROTATEQ 187; This spontaneous report was received from the Registered Nurse, and refers to a patient of unknown age, and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not provided.  On 13-FEB-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1879875, expiration date: 19-NOV-2023, administered orally for prophylaxis (strength was not provided); haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #W015926, expiration date: 14-FEB-2025, administered for prophylaxis (strength, and route of administration were not provided); varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #W024335, expiration date: 01-AUG-2024, administered for prophylaxis (strength, and route of administration were not provided); and sterile diluent, solution for injection/infusion (strength, lot #, expiry date, route of administration, and indication were not provided). The aforementioned vaccines experienced temperature excursion over the weekend: haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), and rotavirus vaccine, live, oral, pentavalent (ROTATEQ): temperature above 9 Celsius degrees (13.25 C), time frame: 2 hours 32 minutes and 0 seconds (no previous temperature excursion); varicella virus vaccine live (oka/merck) (VARIVAX): temperature -10 Celsius degrees up to 8 Celsius degrees (-9.91 C), time frame: 1 hour 40 minutes 0 seconds, (no previous temperature excursion) (product storage error). No additional adverse events were provided.
This spontaneous report was received from a pharmacist regarding an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date in between 22-MAR-2017 to 01-AUG-2017, the patients' received unspecified doses of improperly stored VARIVAX (lot #, expiration date, dose and route were not reported) (incorrect product storage) reconstituted with properly stored sterile diluent (Manufacturer unknown) for prophylaxis. The vaccinations were occurred from 22-MAR-2017 to 01-AUG-2017. The storage temperature was 13.3F and time frame was 2.5 hours. The previous temperature excursion was 14.4F for 2 hours. Data logger was not used. No adverse effects was reported. This is one of the report received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1708USA001247: US-009507513-1708USA001247:
vertigo; topples over all the time; This is a spontaneous report from a contactable consumer(patient). A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0187), via an unspecified route of administration, administered in the right arm on 16Jul2021 (at the age of 58 years old; as reported) as dose 2, single for COVID-19 immunization. Medical history included tachycardia from an unknown date (for probably 20 years) and unknown if ongoing. There were no other vaccinations within four weeks prior to the first administration date of the suspect vaccine. There were no concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EW0178, expiry date: 21Aug2021), via an unspecified route of administration, administered in the right arm (near rotator cuff) on 08Jun2021 (at the age of 58 years old; as reported) as dose 1, single for COVID-19 immunization and experienced vertigo, blood pressure went up so high, terrible brain fog, nausea, anxiety so bad and tunnel vision; measles vaccination for immunization (this was so long ago, the caller's child is now 25 years old); and small pox vaccination for immunization (in the 4th grade). The patient experienced vertigo and topples over all the time on an unspecified date in Jul2021. It was reported that the patient received both doses Pfizer Covid vaccine and has been left with vertigo. The vertigo was horrible, and she toppled over all the time. She has accrued so many medical bills. She had to have her brain looked at. It was also reported that the patient visited the emergency room and was discharged from the emergency room each time. She has never had Covid. But her father died of Covid and her husband had Covid. The patient underwent lab tests and procedures which included antibodies: 100 % (just after receiving the first dose Pfizer Covid vaccine) in Jun2021, blood pressure: 110/80 (prior to receiving the first dose) in 2021, blood pressure: 146/80 in Jun2021, EKG: unknown results in Jun2021, enzymes: unknown results in Jun2021, tested for red measles: no antibodies on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
My adverse event started on 10/04/2022 in the afternoon. I got off from a work meeting and as soon as I took off my headset  suddenly I couldn't hear on my right ear. I thought may be I got water inside my right ear. On Wednesday at night I woke up with extreme vertigo and vomiting. On my 3rd day  on 10/07/2022 I went to the ER. The doctor told me that I had an ear infection. He prescribed  an ear drop with Steroids and Antibiotics. On Thursday  11/10/2022  I went to the ENT. They did the hearing test on me and started treatment me with oral Steroids. I had 3 injections through my ear to my ear drum. It helped a little but I am still experiencing   hearing loss.  I don't think I will ever get it back . Now I am using a hearing aid on my right ear.  This never happened before. I don't know what it caused to lose my hearing.